AI assistant
Sending…
Dr. Lal Pathlabs Limited — Remuneration Information 2021
Jul 29, 2021
61783_rns_2021-07-29_8025bed7-0da2-4809-aa73-5c49c22d7b34.pdf
Remuneration Information
Open in viewerOpens in your device viewer
==> picture [24 x 49] intentionally omitted <==
==> picture [253 x 29] intentionally omitted <==
==> picture [198 x 89] intentionally omitted <==
==> picture [555 x 39] intentionally omitted <==
| SI.No.a)b) | Particulars | Particulars | Details | |
|---|---|---|---|---|
| Brief details of Options granted | 750 (Seven Hundred and FiftyOnly) Options have been grantedbytheNomination&RemunerationCommitteeonJuly29,2021 . | |||
| Whether the scheme is in termsofSEBI(SBEB)Regulations,2014(if applicable) | Yes | |||
| c) | Total number of shares covered by theseOptions | 750 (Seven Hundred and FiftyOnly) equity sharesofface valueof Rs. 10/-each fully paid-up | ||
| d) | Pricing formula | Exercise price ofRs.10/- peroption | ||
| e) | Options vested | Not aoolicable | ||
| f) | Timewithin whichOption may be exercised | 5 yearsfromthe date ofvesting | ||
| g) | Options exercised | Not aoolicable | ||
| h) | Moneyrealized byexerciseofOptions | Not applicable | ||
| i) | The total numberofshares arisof exercise of Option | ing as a result | Not applicable | |
| j) | Options lapsed | Not applicable | ||
| k) | Variation of terms of Options | Thereisnovariation | ||
| I) | Brief details of significant terms | Only vested Options canbeexercised within the exercise | ||
| period. Options shall vest after 1 | ||||
| year but within 4 years from thedate of grant subject satisfactionofvesting conditions. Options notid ihi i id | ||||
| exercse wtn exercse peroshall lapse. | ||||
| m) | Subsequent changesor cancellationorexercise ofsuchOptions | Thereisno change, cancellationorexercise. | ||
| n) | Diluted earnings per share pursuant to issueofequity shares onexercise ofOptions | Options are yet to be exercised |
==> picture [151 x 83] intentionally omitted <==
More from Dr. Lal Pathlabs Limited
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Call Transcript
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
M&A Activity
2026
May 1
Report Publication Announcement
2026
May 1
Regulatory Filings
2026
Apr 30
Investor Presentation
2026
Apr 30
Earnings Release
2026
Apr 30